HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Co-occurrence of developmental delays in a screening study of 4-year-old Finnish children.

Abstract
The aim of this population study was to examine the severity and prevalence of co-occurring developmental delays in 4-year-old children, the rate of overlapping problems, and sex differences. A sample of 434 children (196 males, 238 females; mean age 4 years 3 months, SD 1 month) were administered the 'Lene' test: a comprehensive neurodevelopmental screening test. Results suggest that co-occurrence of attention-behavioural, motor-perceptual, and language delays occurring in school-aged children could already be detected at the age of 4 years. Isolated delays were usually mild, but co-occurring difficulties were mostly moderate or severe. Overlap between developmental delays depended on the severity of the problems. It emerged that males had more severe and more often co-occurring problems than females. Co-occurrence of developmental delays as a risk factor at the early stage of development is discussed.
AuthorsRiitta Valtonen, Timo Ahonen, Paula Lyytinen, Heikki Lyytinen
JournalDevelopmental medicine and child neurology (Dev Med Child Neurol) Vol. 46 Issue 7 Pg. 436-43 (Jul 2004) ISSN: 0012-1622 [Print] England
PMID15230455 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Catchment Area, Health
  • Child
  • Child, Preschool
  • Cognition Disorders (diagnosis, epidemiology)
  • Cohort Studies
  • Comorbidity
  • Developmental Disabilities (diagnosis, epidemiology)
  • Factor Analysis, Statistical
  • Female
  • Finland (epidemiology)
  • Humans
  • Language Disorders (diagnosis, epidemiology)
  • Male
  • Mass Screening (methods)
  • Motor Skills Disorders (diagnosis, epidemiology)
  • Speech Disorders (diagnosis, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: